These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32554756)

  • 21. Ion channels as targets to treat cystic fibrosis lung disease.
    Martin SL; Saint-Criq V; Hwang TC; Csanády L
    J Cyst Fibros; 2018 Mar; 17(2S):S22-S27. PubMed ID: 29102290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis.
    Reihill JA; Douglas LEJ; Martin SL
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33810137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of metals in GOLD4 COPD lungs is associated with decreased CFTR levels.
    Hassan F; Xu X; Nuovo G; Killilea DW; Tyrrell J; Da Tan C; Tarran R; Diaz P; Jee J; Knoell D; Boyaka PN; Cormet-Boyaka E
    Respir Res; 2014 Jun; 15(1):69. PubMed ID: 24957904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease.
    Dransfield M; Rowe S; Vogelmeier CF; Wedzicha J; Criner GJ; Han MK; Martinez FJ; Calverley P
    Am J Respir Crit Care Med; 2022 Mar; 205(6):631-640. PubMed ID: 34982651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
    Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
    PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired Cystic Fibrosis Transmembrane Conductance Regulator Deficiency.
    Cho DY; Woodworth BA
    Adv Otorhinolaryngol; 2016; 79():78-85. PubMed ID: 27466849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CFTR: cystic fibrosis and beyond.
    Mall MA; Hartl D
    Eur Respir J; 2014 Oct; 44(4):1042-54. PubMed ID: 24925916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucins and CFTR: Their Close Relationship.
    Okuda K; Shaffer KM; Ehre C
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia.
    Lin VY; Fain MD; Jackson PL; Berryhill TF; Wilson LS; Mazur M; Barnes SJ; Blalock JE; Raju SV; Rowe SM
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):162-173. PubMed ID: 30576219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic potential of CFTR modulators for COPD and other airway diseases.
    Solomon GM; Fu L; Rowe SM; Collawn JF
    Curr Opin Pharmacol; 2017 Jun; 34():132-139. PubMed ID: 29132121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Grand DL; Gosling M; Baettig U; Bahra P; Bala K; Brocklehurst C; Budd E; Butler R; Cheung AK; Choudhury H; Collingwood SP; Cox B; Danahay H; Edwards L; Everatt B; Glaenzel U; Glotin AL; Groot-Kormelink P; Hall E; Hatto J; Howsham C; Hughes G; King A; Koehler J; Kulkarni S; Lightfoot M; Nicholls I; Page C; Pergl-Wilson G; Popa MO; Robinson R; Rowlands D; Sharp T; Spendiff M; Stanley E; Steward O; Taylor RJ; Tranter P; Wagner T; Watson H; Williams G; Wright P; Young A; Sandham DA
    J Med Chem; 2021 Jun; 64(11):7241-7260. PubMed ID: 34028270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.
    Mall MA; Mayer-Hamblett N; Rowe SM
    Am J Respir Crit Care Med; 2020 May; 201(10):1193-1208. PubMed ID: 31860331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
    Kunzelmann K; Mall M
    Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.
    Raju SV; Jackson PL; Courville CA; McNicholas CM; Sloane PA; Sabbatini G; Tidwell S; Tang LP; Liu B; Fortenberry JA; Jones CW; Boydston JA; Clancy JP; Bowen LE; Accurso FJ; Blalock JE; Dransfield MT; Rowe SM
    Am J Respir Crit Care Med; 2013 Dec; 188(11):1321-30. PubMed ID: 24040746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic obstructive pulmonary disease and the modulation of CFTR by acute exposure to cigarette smoke.
    Hanrahan JW; Abu-Arish A; Wong FH; Turner MJ; Carlile GW; Thomas DY; Cantin AM
    Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1374-C1392. PubMed ID: 36121129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine.
    Carrasco-Hernández L; Quintana-Gallego E; Calero C; Reinoso-Arija R; Ruiz-Duque B; López-Campos JL
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel.
    Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE
    Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis.
    Elborn JS
    Lancet; 2016 Nov; 388(10059):2519-2531. PubMed ID: 27140670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.
    Woodworth BA
    Laryngoscope; 2015 Oct; 125 Suppl 7(0 7):S1-S13. PubMed ID: 25946147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.